These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32931153)

  • 1. Fine-needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case series with predominantly indeterminate cytology.
    Abi-Raad R; Prasad ML; Adeniran AJ; Cai G
    Cancer Cytopathol; 2020 Nov; 128(11):803-811. PubMed ID: 32931153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomorphologic features of NTRK-rearranged thyroid carcinoma.
    Viswanathan K; Chu YH; Faquin WC; Sadow PM
    Cancer Cytopathol; 2020 Nov; 128(11):812-827. PubMed ID: 33074583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
    Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
    Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTRK-rearranged papillary thyroid carcinoma demonstrates frequent subtle nuclear features and indeterminate cytologic diagnoses.
    Lee YC; Hsu CY; Lai CR; Hang JF
    Cancer Cytopathol; 2022 Feb; 130(2):136-143. PubMed ID: 34644010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight Cases.
    Shih KP; Lee YC; Tsai JJ; Lin SH; Liu CY; Li WS; Li CF; Hang JF
    Endocr Pathol; 2024 Jun; 35(2):134-146. PubMed ID: 38642308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions.
    Tondi Resta I; Rind A; Montone KT; Livolsi VA; Baloch ZW
    Hum Pathol; 2024 Jul; 149():29-38. PubMed ID: 38857659
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [No Abstract]   [Full Text] [Related]  

  • 9. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).
    Chu YH; Dias-Santagata D; Farahani AA; Boyraz B; Faquin WC; Nosé V; Sadow PM
    Mod Pathol; 2020 Nov; 33(11):2186-2197. PubMed ID: 32457407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
    Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients.
    Darbinyan A; Morotti R; Cai G; Prasad ML; Christison-Lagay E; Dinauer C; Adeniran AJ
    Cancer Cytopathol; 2020 Oct; 128(10):746-756. PubMed ID: 32897650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid paraganglioma: A diagnostic pitfall in thyroid FNA.
    Satturwar SP; Rossi ED; Maleki Z; Cantley RL; Faquin WC; Pantanowitz L
    Cancer Cytopathol; 2021 Jun; 129(6):439-449. PubMed ID: 33232572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillae, psammoma bodies, and/or many nuclear pseudoinclusions are helpful criteria but should not be required for a definitive cytologic diagnosis of papillary thyroid carcinoma: An institutional experience of 207 cases with surgical follow up.
    Elsheikh TM; Thomas M; Brainard J; Di Marco J; Manosky E; Springer B; Underwood D; Chute DJ
    Cancer Cytopathol; 2024 Jun; 132(6):348-358. PubMed ID: 38563725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Chandler JB; Colunga M; Prasad ML; Callender GG; Quinn C; Chhieng D; Adeniran AJ
    Cancer Cytopathol; 2017 Nov; 125(11):865-875. PubMed ID: 28834409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
    Ohori NP; Singhal R; Nikiforova MN; Yip L; Schoedel KE; Coyne C; McCoy KL; LeBeau SO; Hodak SP; Carty SE; Nikiforov YE
    Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology.
    Kitano M; Sugitani I; Toda K; Ikenaga M; Motoi N; Yamamoto N; Hotomi M; Fujimoto Y; Kawabata K
    Surg Today; 2013 Jun; 43(6):632-7. PubMed ID: 23076684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse sclerosing variant of papillary thyroid carcinoma: a study of fine needle aspiration cytology in 20 patients.
    Takagi N; Hirokawa M; Nobuoka Y; Higuchi M; Kuma S; Miyauchi A
    Cytopathology; 2014 Jun; 25(3):199-204. PubMed ID: 23781895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Bongiovanni M; Mermod M; Canberk S; Saglietti C; Sykiotis GP; Pusztaszeri M; Ragazzi M; Mazzucchelli L; Giovanella L; Piana S
    Cancer Cytopathol; 2017 Jun; 125(6):389-397. PubMed ID: 28374549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.